Thomas Adocker

Prix à l'honneur

JUVE Patent Austria Ranking 2023

Leading individual (“high level of expertise, great dedication to his cases”, competitor)

For more than twenty years, Thomas has been advising national and international clients in the field of intellectual property, with a strong focus on patent law, in particular with respect to litigation, licensing and technology transfer. He has established an excellent reputation for representing clients in major Austrian patent infringement cases and is known for his broad know-how in connection with multinational disputes. Amongst the Austrian lawyers, he is the most experienced in UPC litigation.

In addition to his extensive regulatory expertise, Thomas is also frequently active in franchise law and deals with distribution agreements.

The Unified Patent Court (UPC)

The UPC and Unitary Patent will introduce the most radical changes to patent litigation in Europe in 40 years.

Read our guide to the UPC

Advertising Medical Devices European Comparison Tool

Looking to promote your medical device products in Europe? Access our comparison tool to manage regulatory challenges across multiple jurisdictions.

Access here

CV

2023 Partner, Taylor Wessing

2006 - 2023 Partner, Schwarz Schönher Attworneys at law

2001 - 2005 Associate, Engin-Deniz Attorneys at law

Carrière

2023 Partner, Taylor Wessing

2006 - 2023 Partner, Schwarz Schönher Attworneys at law

2001 - 2005 Associate, Engin-Deniz Attorneys at law

Formation

2005 Austrian Bar exam, Vienna

2000 Summer Term, Miami University, Oxford/Ohio, USA

1996 – 2000 Legal studies, University of Vienna

Publications

Contribution on the commentary by Stadler/Koller on the Austrian Patent Act (1^st ed. July 2019, 2^nd ed. forthcoming): incl. commentary on the elements of infringement and the provisions on the statute of limitations

Contribution to the textbook by Hüttermann "Einheitspatent und Einheitliches Patentgericht" (1^st ed. Dec 2016, 2^nd ed. forthcoming): Presentation of the Austrian legal situation and the differences to the Unified Patent Court System

Contribution on the commentary by Hüpfauf/Koller on the Austrian Medical Devices Act (1^st edition forthcoming, expected 2024): Distinction between Medical Devices Act and Blood Regulatory Rules

Zivilrechtliche Hausdurchsuchung und Beweissicherung nach Enforcement Directive und § 151b PatG (ecolex 2020, 669)

Zur Zulässigkeit der Einschränkung eines Patents durch Aufnahme von Merkmalen aus dessen Beschreibung in den Anspruch (OPM, Op 1/13 – ÖBl-LS 2014/20)

Zum Ersatz von Kosten der patentanwaltlichen Vertretung und Gutachtenserstellung im Patentverletzungsverfahren (OLG Wien, 15 R 109/12b – ÖBl-LS 2013/18)

Zur Zulässigkeit eines in Österreich nicht rezeptpflichtigen Medikaments (OGH 4 Ob 13/12h – Arzneimittel-Versandhandel II – ÖBl 2012/65)

Zur Zulässigkeit der Erteilung eines ergänzenden Schutzzertifikats (EuGH C-427/09, ÖBl-LS 2011/117)

Österreichischer Oberster Patent- und Markensenat trifft Grundsatzentscheidung zum Verhältnis zwischen der Erfindungshöhe eines Patents und eines Gebrauchsmusters (OPM, OGM 1/10 – Teleskopausleger, GRUR Int 2011, 673)

Nichtigkeit eines ergänzenden Schutzzertifikats und dessen Geltendmachung (OGH, 17 Ob 6/10x – Memantin, GRUR Int 2011, 385)

Vermögenswerte Interessen aus dem Namensrecht (OGH, 17 Ob 2/10h – Maria Treben, ecolex 2010/438)